Literature DB >> 15194004

Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells.

Jun Wen1, Yiwei Zhang, Xiaoqing Chen, Lingbo Shen, Gloria C Li, Ming Xu.   

Abstract

We examined the effects of diallyl disulfide (DADS), an oil-soluble organosulfur compound found in garlic, on human HepG2 hepatoma cells to better understand its effect on apoptosis and apoptosis-related genes. Our study has demonstrated that DADS affects cell proliferation activity and viability and elicits typical apoptotic morphologic changes (chromatic condensation and nuclear fragmentation) in human HepG2 hepatoma cells. Also, treatment with DADS induces a temporary increase in phosphorylated p38 MAPK (phospho-p38) and phosphorylated p42/44 MAPK (phospho-p42/p44) in a time- and concentration-dependent manner. Inhibition of activated/phosphorylated mitogen-activated protein kinase (MAPK) with phospho-p38 or phospho-p42/44 specific inhibitors, SB203580 or U0126, induces apoptosis without DADS treatment, indicating that at least the endogenous activated forms of p38 MAPK and p42/p44 MAPK markedly exert cytoprotective roles from cell apoptosis in the HepG2 hepatoma cells. Combined treatment with these inhibitors followed by DADS further enhances the DADS-induced apoptosis. Taken together, these results show that both DADS and the specific inhibitors of MAPKs could induce apoptosis in HepG2 hepatoma cells and that the MAPKs inhibitors further enhance the apoptotic effect in DADS-treated HepG2 hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194004     DOI: 10.1016/j.bcp.2004.03.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Diallyl disulfide induces apoptosis and autophagy via mTOR pathway in myeloid leukemic cell line.

Authors:  Tanitta Suangtamai; Dalina I Tanyong
Journal:  Tumour Biol       Date:  2016-02-19

2.  The roles of p38MAPK and caspase-3 in DADS-induced apoptosis in human HepG2 cells.

Authors:  Chunxiao Ji; Fenglian Ren; Heng Ma; Ming Xu
Journal:  J Exp Clin Cancer Res       Date:  2010-05-18

3.  Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.

Authors:  Xueli Bai; Lihua Wu; Tingbo Liang; Zhiqiang Liu; Junjian Li; Donglin Li; Haiyang Xie; Shengyong Yin; Jun Yu; Qi Lin; Shusen Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

4.  Prevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by S-allylcysteine.

Authors:  Sivapatham Sundaresan; Perumal Subramanian
Journal:  Mol Cell Biochem       Date:  2008-01-06       Impact factor: 3.396

5.  Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway.

Authors:  Guojun Wang; Guanghui Liu; Yanwei Ye; Yang Fu; Xiefu Zhang
Journal:  Oncol Lett       Date:  2016-02-24       Impact factor: 2.967

Review 6.  Recent Research Progress on Garlic ( dà suàn) as a Potential Anticarcinogenic Agent Against Major Digestive Cancers.

Authors:  Rajasekaran Raghu; Kuan-Hung Lu; Lee-Yan Sheen
Journal:  J Tradit Complement Med       Date:  2012-07

7.  Synthesis, identification and anti-cancer activity of 1-(4-methylpent-2-enyl)-2-(4-phenylbut-2-enyl)disulfane.

Authors:  Chunxiao Ji; Fenglian Ren; Ming Xu
Journal:  Molecules       Date:  2010-08-16       Impact factor: 4.411

8.  GADD45a Regulates Olaquindox-Induced DNA Damage and S-Phase Arrest in Human Hepatoma G2 Cells via JNK/p38 Pathways.

Authors:  Daowen Li; Chongshan Dai; Xiayun Yang; Bin Li; Xilong Xiao; Shusheng Tang
Journal:  Molecules       Date:  2017-01-13       Impact factor: 4.411

9.  Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways.

Authors:  Dong Yeok Shin; Gi-Young Kim; Jun Hyuk Lee; Byung Tae Choi; Young Hyun Yoo; Yung Hyun Choi
Journal:  Int J Mol Sci       Date:  2012-11-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.